SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/191A765C67BE36180A8F1BD64D912FB57930C00625DCC80FCEE9F5D635039F3191BC8C421E6279991B70B425314FB198>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/191A765C67BE36180A8F1BD64D912FB57930C00625DCC80FCEE9F5D635039F3191BC8C421E6279991B70B425314FB198
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/191A765C67BE36180A8F1BD64D912FB57930C00625DCC80FCEE9F5D635039F3191BC8C421E6279991B70B425314FB198
http://www.w3.org/2000/01/rdf-schema#comment
"Beta2 integrin expression showed a 3-4-fold increase in the combined treatment group at all time points and kept increasing till day 56"
xsd:string
http://purl.uniprot.org/uniprot/#_760C483313885F899785C600516036C5F8296839AECB175137FD04EF57B882A55BC160BC1012BB575EB1AFA27749EC76
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/191A765C67BE36180A8F1BD64D912FB57930C00625DCC80FCEE9F5D635039F3191BC8C421E6279991B70B425314FB198
http://purl.uniprot.org/uniprot/Q4KLK5
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/191A765C67BE36180A8F1BD64D912FB57930C00625DCC80FCEE9F5D635039F3191BC8C421E6279991B70B425314FB198
http://purl.uniprot.org/uniprot/#_Q4KLK5-mappedCitation-23830386
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/191A765C67BE36180A8F1BD64D912FB57930C00625DCC80FCEE9F5D635039F3191BC8C421E6279991B70B425314FB198